183 related articles for article (PubMed ID: 31570994)
1. Intranasal immunization with coxsackievirus A16 virus-like particles confers protection against lethal infection in neonatal mice.
Chen X; Zhang Y; Mao N; Zhu S; Ji T; Xu W
Arch Virol; 2019 Dec; 164(12):2975-2984. PubMed ID: 31570994
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice.
Sun S; Gao F; Mao Q; Shao J; Jiang L; Liu D; Wang Y; Yao X; Wu X; Sun B; Zhao D; Ma Y; Lu J; Kong W; Jiang C; Liang Z
Hum Vaccin Immunother; 2015; 11(10):2406-13. PubMed ID: 26036916
[TBL] [Abstract][Full Text] [Related]
3. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z
Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.
Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S
Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
7. A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection.
Zhou Y; Zhang C; Liu Q; Gong S; Geng L; Huang Z
Antiviral Res; 2018 Apr; 152():124-130. PubMed ID: 29470994
[TBL] [Abstract][Full Text] [Related]
8. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H
Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164
[TBL] [Abstract][Full Text] [Related]
9. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model.
Jin WP; Lu J; Zhang XY; Wu J; Wei ZN; Mai JY; Qian SS; Yu YT; Meng SL; Wang ZJ; Shen S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408178
[TBL] [Abstract][Full Text] [Related]
11. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
12. VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment.
Chen FH; Liu X; Fang HL; Nan N; Li Z; Ning NZ; Luo DY; Li T; Wang H
Front Immunol; 2019; 10():2564. PubMed ID: 31787970
[TBL] [Abstract][Full Text] [Related]
13. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z
Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102
[TBL] [Abstract][Full Text] [Related]
14. Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice.
Zhang C; Liu Q; Ku Z; Hu Y; Ye X; Zhang Y; Huang Z
Antiviral Res; 2016 May; 129():47-51. PubMed ID: 26902108
[TBL] [Abstract][Full Text] [Related]
15. Immune responses of a CV-A16 live attenuated candidate strain and its protective effects in rhesus monkeys.
Yang T; Xie T; Li H; Song X; Yue L; Wang X; Shen D; Ma K; Jiang Q; Long R; Yang R; He X; Zhang Y; Xie Z; Li Q
Emerg Microbes Infect; 2020 Dec; 9(1):2136-2146. PubMed ID: 32930072
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model.
Qian SS; Wei ZN; Jin WP; Wu J; Zhou YP; Meng SL; Guo J; Wang ZJ; Shen S
Emerg Microbes Infect; 2021 Dec; 10(1):763-773. PubMed ID: 33739899
[TBL] [Abstract][Full Text] [Related]
17. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.
Mao Q; Wang Y; Shao J; Ying Z; Gao F; Yao X; Li C; Ye Q; Xu M; Li R; Zhu F; Liang Z
Hum Vaccin Immunother; 2015; 11(11):2723-33. PubMed ID: 25715318
[TBL] [Abstract][Full Text] [Related]
18. Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice.
Zhao H; Li HY; Han JF; Deng YQ; Li YX; Zhu SY; He YL; Qin ED; Chen R; Qin CF
Appl Microbiol Biotechnol; 2013 Dec; 97(24):10445-52. PubMed ID: 24085395
[TBL] [Abstract][Full Text] [Related]
19. Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections.
Liu J; Zhao B; Xue L; Wu J; Xu Y; Liu Y; Qin C
Virol J; 2020 Apr; 17(1):58. PubMed ID: 32321526
[TBL] [Abstract][Full Text] [Related]
20. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses.
Cai Y; Ku Z; Liu Q; Leng Q; Huang Z
Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
